Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review.
about
Safety and efficacy of long-term outpatient ertapenem therapy.Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?Effects of Group 1 versus Group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems: a before and after intervention study of carbapenem-use stewardship.Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae.
P2860
Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ertapenem use and antimicrobia ...... fections: a systematic review.
@en
type
label
Ertapenem use and antimicrobia ...... fections: a systematic review.
@en
prefLabel
Ertapenem use and antimicrobia ...... fections: a systematic review.
@en
P2860
P356
P1476
Ertapenem use and antimicrobia ...... fections: a systematic review.
@en
P2093
Anastasios Kapaskelis
Giannoula S Tansarli
P2860
P356
10.1586/ERI.12.149
P577
2013-01-01T00:00:00Z